Unique ID issued by UMIN | UMIN000048811 |
---|---|
Receipt number | R000055620 |
Scientific Title | A randomized, double-blind, placebo-controlled, crossover comparative study of evaluation of sleep-improvement effects of the capsules containing Valeriana fauriei root (VF) extract |
Date of disclosure of the study information | 2022/09/04 |
Last modified on | 2022/08/31 23:53:29 |
Evaluation of sleep-improvement effects of the capsules containing Valeriana fauriei root (VF) extract
Evaluation of sleep-improvement effects of the capsules containing VF extract
A randomized, double-blind, placebo-controlled, crossover comparative study of evaluation of sleep-improvement effects of the capsules containing Valeriana fauriei root (VF) extract
Evaluation of sleep-improvement effects of the capsules containing VF extract
Japan |
Healthy Japanese subjects
Not applicable |
Others
NO
Examine the effects of taking capsules containing VF extract on sleep.
Efficacy
Confirmatory
Pragmatic
Not applicable
Evaluation of sleep quality based on the Obstructive sleep apnea syndrome (OSA) Sleep Questionnaire.
Evaluation of sleep quality using the OSA Sleep Questionnaire for each sleep complaint on the Athens Insomnia Scale (AIS).
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
Institution is not considered as adjustment factor.
2
Treatment
Food |
Duration: 2 weeks
Trial food: Soft capsule containing VF extract (1 g/1 capsule)
Dosage and administration: Take 2 capsules (equivalent to 2 g of VF extract) with water 30 minutes before bedtime.
Duration: 2 weeks
Trial food: Placebo soft capsule (Same form as the VF capsule, with the same odor)
Dosage and administration: Take 2 capsules with water 30 minutes before bedtime.
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1. Subjects with sleep problems.
2. Subjects with an AIS score of 6 or higher.
3. Subjects with written consent to take part in the trial.
4. Men or women aged 20 to 65.
5. Subjects with an easy intake of capsules.
6. Subjects who can complete the questionnaire via smartphone, tablet, or computer.
1. Subjects currently being treated for severe renal or liver disease, heart, respiratory or endocrine disease, or other metabolic diseases.
2. Subjects currently taking medications that interfere with sleep (sleeping pills, antianxiety drugs)
3. Subjects allergic to gelatin.
4. Subjects work irregular/night/early morning shifts every day.
5. Women having the possibility or intention to become pregnant, lactating
70
1st name | Shunsuke |
Middle name | |
Last name | Nojiri |
Nagoya City University Hospital
East-Asian traditional medicine center
4678601
1 Kawazumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan
+81528538211
snojiri@med.nagoya-cu.ac.jp
1st name | Misato |
Middle name | |
Last name | Ota |
Kuki Sangyo Co., Ltd.
R&D Medicinal Department
510-0059
11 Onoe-cho, Yokkaichi-shi, Mie, Japan.
059-350-2050
m_oota@kuki-info.co.jp
Nagoya City University Hospital
Kuki Sangyo Co., Ltd.
R&D Medicinal Department
Profit organization
IRB Office, Clinical Research Development Support Center, Nagoya City University Hospital
1 Kawazumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan
052-853-8348
irb_jimu@med.nagoya-cu.ac.jp
NO
2022 | Year | 09 | Month | 04 | Day |
Unpublished
Preinitiation
2022 | Year | 06 | Month | 13 | Day |
2022 | Year | 08 | Month | 05 | Day |
2022 | Year | 10 | Month | 18 | Day |
2022 | Year | 12 | Month | 31 | Day |
2022 | Year | 09 | Month | 01 | Day |
2022 | Year | 08 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055620